The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
GERON CORP COM 374163103   33,877,216 9,569,835 SH   SOLE   9,569,835 0 0
INSMED INC COM PAR $.01 457669307   894,795,544 12,960,538 SH   SOLE   12,960,538 0 0
JAZZ PHARMACEUTICALS PLC SHS USD G50871105   59,668,022 484,515 SH   SOLE   484,515 0 0
KEROS THERAPEUTICS INC COM 492327101   26,707,347 1,687,135 SH   SOLE   1,687,135 0 0
NURIX THERAPEUTICS INC COM 67080M103   3,083,750 163,681 SH   SOLE   163,681 0 0
VERONA PHARMA PLC SPONSORED ADS 925050106   37,637,252 810,449 SH   SOLE   810,449 0 0